Therapeutic and diagnostic applications of nanoparticles in the management of COVID-19: a comprehensive overview

O Gholizadeh, S Yasamineh, P Amini, H Afkhami… - Virology Journal, 2022 - Springer
Abstract In December 2019, Coronavirus Disease 2019 (COVID-19) was reported in Wuhan,
China. Comprehensive strategies for quick identification, prevention, control, and remedy of …

Effects of microplastic and engineered nanomaterials on inflammatory bowel disease: a review

Y Zhao, S Liu, H Xu - Chemosphere, 2023 - Elsevier
Many microplastics and engineered nanomaterials (ENMs) exist in the daily environment.
The intestinal impact of these exogenous fine particles on inflammatory bowel disease (IBD) …

Glycogen-based pH and redox sensitive nanoparticles with ginsenoside Rh2 for effective treatment of ulcerative colitis

Y Xu, BW Zhu, X Li, YF Li, XM Ye, JN Hu - Biomaterials, 2022 - Elsevier
The purpose of this study is to construct a pH and redox sensitive nanoparticle to effectively
deliver ginsenoside Rh 2 for the treatment of ulcerative colitis (UC). Herein, glycogen was …

[HTML][HTML] Silver nanoparticle based multifunctional approach for combating COVID-19

P Allawadhi, V Singh, A Khurana, I Khurana… - Sensors …, 2021 - Elsevier
COVID-19 is a highly contagious and widespread disease that has strained the global
healthcare system to the hilt. Silver nanoparticles (AgNPs) are well known for their potent …

Chitosan coated copper/silver oxide nanoparticles as carriers of breast anticancer drug: Cyclin D1/P53 expressions and cytotoxicity studies

E Rahimi, F Asefi, A Afzalinia, S Khezri… - Inorganic Chemistry …, 2023 - Elsevier
Developing new treatment strategies for cancer is necessary and inevitable. The aim of this
study is the synthesis of a novel nanocomposite (NC) based on chitosan coated …

“Dual sensitive supramolecular curcumin nanoparticles” in “advanced yeast particles” mediate macrophage reprogramming, ROS scavenging and inflammation …

X Han, R Luo, S Qi, Y Wang, L Dai, W Nie, M Lin… - Journal of …, 2023 - Springer
Ulcerative colitis (UC) faces some barriers in oral therapy, such as how to safely deliver
drugs to the colon and accumulate in the colon lesions. Hence, we report an advanced yeast …

Biomaterials as therapeutic drug carriers for inflammatory bowel disease treatment

CPJ Wang, MJ Byun, SN Kim, W Park, HH Park… - Journal of Controlled …, 2022 - Elsevier
Inflammatory bowel diseases (IBDs) are idiopathic gastrointestinal inflammatory disorders
featuring chronic intestinal inflammation. Although IBDs are increasingly becoming globally …

Taurohyodeoxycholic acid alleviates trinitrobenzene sulfonic acid induced ulcerative colitis via regulating Th1/Th2 and Th17/Treg cells balance

L Lv, Z Chen, W Bai, J Hao, Z Heng, C Meng, L Wang… - Life Sciences, 2023 - Elsevier
Aims Taurohyodeoxycholic acid (THDCA), a natural 6α-hydroxylated bile acid, exhibits
intestinal anti-inflammatory effects. This study aimed to explore the efficacy of THDCA on …

Green synthesis of chitosan-coated magnetic nanoparticles for drug delivery of oxaliplatin and irinotecan against colorectal cancer cells

N Farmanbar, S Mohseni, M Darroudi - Polymer Bulletin, 2022 - Springer
Recently, the green synthesizing methods of nanoparticles found their place in the center of
attention. In this regard. the synthesis of useful nanoparticles such as the magnetic types, as …

Polydopamine-coated thalidomide nanocrystals promote DSS-induced murine colitis recovery through Macrophage M2 polarization together with the synergistic anti …

Z Meng, B Fu, Z Yang, Y Xu, H Huang, Y Bai… - International Journal of …, 2023 - Elsevier
High levels of proinflammatory cytokines, macrophage polarization status and immune-
mediated angiogenesis play pivotal roles in the pathogenesis of inflammatory bowel …